INSUBCONTINENT EXCLUSIVE:
Independent analyst Kunal Bothra has a sell call on Cipla Ltd
with a target price of Rs 522
The current market price of Cipla Ltd
is Rs 536.1 Time period given by analyst is Intra Day when Cipla Ltd
price can reach defined target
Kunal Bothra recommended to keep stoploss at Rs 544
Cipla Ltd., incorporated in 1935, is a largecap company with a market cap of Rs
key Products/Revenue Segments include Tablets Capsules which contributed Rs 6163.98 Crore to Sales Value (56.16 % of Total Sales),
Injections/Sterile Solution which contributed Rs 1506.33 Crore to Sales Value (13.72 % of Total Sales), Aerosols which contributed Rs
1276.00 Crore to Sales Value (11.62 % of Total Sales), Bulk Drugs which contributed Rs 862.17 Crore to Sales Value (7.85 % of Total Sales),
Liquids which contributed Rs 466.89 Crore to Sales Value (4.25 % of Total Sales), Creams which contributed Rs 307.84 Crore to Sales Value
(2.80 % of Total Sales), Export Incentives which contributed Rs 162.31 Crore to Sales Value (1.47 % of Total Sales), Other Operating Revenue
which contributed Rs 112.22 Crore to Sales Value (1.02 % of Total Sales), Others which contributed Rs 53.87 Crore to Sales Value (0.49 % of
Total Sales), Other Services which contributed Rs 36.44 Crore to Sales Value (0.33 % of Total Sales) and Scrap which contributed Rs 26.53
Crore to Sales Value (0.24 % of Total Sales)for the year ending 31-Mar-2017
For the quarter ended 30-09-2018, the company has reported a Consolidated sales of Rs 3947.93 Crore, up 2.65 % from last quarter Sales of
Rs 3845.84 Crore and down -1.01 % from last year same quarter Sales of Rs 3988.24 Crore Company has reported net profit after tax of Rs
366.13 Crore in latest quarter
Mr.S Radhakrishnan, Mr.Umang Vohra, Ms.Ireena Vittal, Ms.Naina Lal Kidwai, Ms.Punita Lal, Ms.Samina Vaziralli
Company has Walker Chandiok Co
LLP as its auditoRs As on 30-09-2018, the company has a total of 805,227,852 shares outstanding.
